272 related articles for article (PubMed ID: 11097832)
1. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen.
Sahin-Tóth M; Tóth M
Biochem Biophys Res Commun; 2000 Nov; 278(2):286-9. PubMed ID: 11097832
[TBL] [Abstract][Full Text] [Related]
2. Trypsinogen stabilization by mutation Arg117-->His: a unifying pathomechanism for hereditary pancreatitis?
Sahin-Tóth M; Gráf L; Tóth M
Biochem Biophys Res Commun; 1999 Oct; 264(2):505-8. PubMed ID: 10529393
[TBL] [Abstract][Full Text] [Related]
3. The pathobiochemistry of hereditary pancreatitis: studies on recombinant human cationic trypsinogen.
Sahin-Tóth M
Pancreatology; 2001; 1(5):461-5. PubMed ID: 12120225
[TBL] [Abstract][Full Text] [Related]
4. [Significance of trypsinogen gene mutations in the etiology of hereditary pancreatitis].
Sahin-Tóth M; Tóth M
Orv Hetil; 2001 Mar; 142(12):603-6. PubMed ID: 11324217
[TBL] [Abstract][Full Text] [Related]
5. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
6. Hereditary pancreatitis-associated mutation asn(21) --> ile stabilizes rat trypsinogen in vitro.
Sahin-Tóth M
J Biol Chem; 1999 Oct; 274(42):29699-704. PubMed ID: 10514442
[TBL] [Abstract][Full Text] [Related]
7. High-affinity Ca(2+) binding inhibits autoactivation of rat trypsinogen.
Sahin-Tóth M; Tóth M
Biochem Biophys Res Commun; 2000 Aug; 275(2):668-71. PubMed ID: 10964720
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology and evolutionary and physiological implications of pancreatitis-associated cationic trypsinogen mutations.
Chen JM; Montier T; Férec C
Hum Genet; 2001 Sep; 109(3):245-52. PubMed ID: 11702203
[TBL] [Abstract][Full Text] [Related]
9. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis.
Sahin-Tóth M
J Biol Chem; 2000 Jul; 275(30):22750-5. PubMed ID: 10801865
[TBL] [Abstract][Full Text] [Related]
10. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.
Teich N; Bauer N; Mössner J; Keim V
Am J Gastroenterol; 2002 Feb; 97(2):341-6. PubMed ID: 11866271
[TBL] [Abstract][Full Text] [Related]
11. Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis.
Räty S; Piironen A; Babu M; Pelli H; Sand J; Uotila S; Nordback I; Herzig KH
Scand J Gastroenterol; 2007 Aug; 42(8):1000-5. PubMed ID: 17613931
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis.
Férec C; Raguénès O; Salomon R; Roche C; Bernard JP; Guillot M; Quéré I; Faure C; Mercier B; Audrézet MP; Guillausseau PJ; Dupont C; Munnich A; Bignon JD; Le Bodic L
J Med Genet; 1999 Mar; 36(3):228-32. PubMed ID: 10204851
[TBL] [Abstract][Full Text] [Related]
13. Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications.
Truninger K; Ammann RW; Blum HE; Witt H
Swiss Med Wkly; 2001 Oct; 131(39-40):565-74. PubMed ID: 11775491
[TBL] [Abstract][Full Text] [Related]
14. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene.
Whitcomb DC; Gorry MC; Preston RA; Furey W; Sossenheimer MJ; Ulrich CD; Martin SP; Gates LK; Amann ST; Toskes PP; Liddle R; McGrath K; Uomo G; Post JC; Ehrlich GD
Nat Genet; 1996 Oct; 14(2):141-5. PubMed ID: 8841182
[TBL] [Abstract][Full Text] [Related]
15. Evidence that hereditary pancreatitis is genetically heterogeneous disorder.
Ravnik-Glavac M; Dean M; di Sant'Agnese P; Chernick M; Kozelj M; Krizman I; Glavac D
Pflugers Arch; 2000; 439(3 Suppl):R50-2. PubMed ID: 10653140
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the cationic trypsinogen in hereditary pancreatitis.
Teich N; Mössner J; Keim V
Hum Mutat; 1998; 12(1):39-43. PubMed ID: 9633818
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the cationic trypsinogen gene in patients with hereditary pancreatitis.
Creighton JE; Lyall R; Wilson DI; Curtis A; Charnley RM
Br J Surg; 2000 Feb; 87(2):170-5. PubMed ID: 10671922
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the cationic trypsinogen gene in patients with pancreatic cancer.
Hengstler JG; Bauer A; Wolf HK; Bulitta CJ; Tanner B; Oesch F; Gebhard S; Boettger T
Anticancer Res; 2000; 20(5A):2967-74. PubMed ID: 11062709
[TBL] [Abstract][Full Text] [Related]
19. Hereditary pancreatitis and mutations of the cationic trypsinogen gene.
O'Reilly DA; Kingsnorth AN
Br J Surg; 2000 Jun; 87(6):708-17. PubMed ID: 10928807
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel pancreatitis-associated missense mutation, R116C, in the human cationic trypsinogen gene (PRSS1).
Le Maréchal C; Bretagne JF; Raguénès O; Quéré I; Chen JM; Ferec C
Mol Genet Metab; 2001 Nov; 74(3):342-4. PubMed ID: 11708864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
